StocksAstraZeneca PLC ADRAZN

AZN

AstraZeneca PLC ADR

65.95 -0.12 (-0.18%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
65.89
B
66.02

Overview

Prev Close65.95
Day's Range 64.00 - 65.89
52 Week Range 53.58 - 71.63
Average Volume (3m)6.95M
1-Year Return10.13%
Beta0.5793
Market Cap207.32B
P/E Ratio473.61
Revenue41.59B
EPS-0.33
Dividend (Yield)1.405 (2.13%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.720/01/202231/03/202213/06/202257.5060.0062.5065.0067.5070.0072.50
Chart times in UTC
Industry Pharmaceuticals Major
CEO Pascal Soriot, MBA, DVM
Employees 83,100

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: AstraZeneca PLC ADR's revenues increased by 38.48% and amounted to 38.51B. Net income decreased by 96.37% to 115.00M. Net assets increased by 151.23% to 39.29B and EPS decreased from 1.23 to 0.04.
AZN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
57.36%
Net Profit Margin
8.09%
Operating Margin
5.35%
Return On Investment
6.26%
06/21
09/21
12/21
03/22
Total Revenue
8.2B
9.87B
12.01B
11.39B
Gross Profit
6.02B
5.03B
6.18B
6.9B
Operating Income
1.07B
-100M
N/A
855M
Net Income
548.93M
-1.65B
-346M
388M